The current evidence indicates that serum GP73 has a comparable accuracy to AFP for the diagnosis of HCC, while the value of serum GP73 in combination with AFP for HCC detection deserves further investigation. This evidence concerns the gene GOLM1 and hepatocellular carcinoma.